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Abstract
Old World frugivorous bats have been identified as natural hosts for emerging zoonotic viruses of significant public health
concern, including henipaviruses (Nipah and Hendra virus), Ebola virus, and Marburg virus. Epidemiological studies of these
viruses in bats often utilize serology to describe viral dynamics, with particular attention paid to juveniles, whose birth
increases the overall susceptibility of the population to a viral outbreak once maternal immunity wanes. However, little is
understood about bat immunology, including the duration of maternal antibodies in neonates. Understanding duration of
maternally derived immunity is critical for characterizing viral dynamics in bat populations, which may help assess the risk of
spillover to humans. We conducted two separate studies of pregnant Pteropus bat species and their offspring to measure
the half-life and duration of antibodies to 1) canine distemper virus antigen in vaccinated captive Pteropus hypomelanus;
and 2) Hendra virus in wild-caught, naturally infected Pteropus alecto. Both of these pteropid bat species are known
reservoirs for henipaviruses. We found that in both species, antibodies were transferred from dam to pup. In P. hypomelanus
pups, titers against CDV waned over a mean period of 228.6 days (95% CI: 185.4–271.8) and had a mean terminal phase half-
life of 96.0 days (CI 95%: 30.7–299.7). In P. alecto pups, antibodies waned over 255.13 days (95% CI: 221.0–289.3) and had a
mean terminal phase half-life of 52.24 days (CI 95%: 33.76–80.83). Each species showed a duration of transferred maternal
immunity of between 7.5 and 8.5 months, which was longer than has been previously estimated. These data will allow for
more accurate interpretation of age-related Henipavirus serological data collected from wild pteropid bats.
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Introduction
Old world frugivorous bats of the genus Pteropus (family
Pteropodidae) are reservoirs for important zoonotic paramyxoviruses,
including Nipah virus and Hendra virus – both members of the
genus Henipavirus (family Paramyxoviridae). Both Hendra and Nipah
viruses have been associated with severe neurological and
respiratory disease and high mortality rates in domestic animals
and humans [1]. Hendra virus is enzootic in pteropid bats in
Australia, while Nipah and Nipah-like viruses have been identified
in Pteropus species throughout Asia and in other related pteropodid
bat species in Africa [2–12]. Field and laboratory studies have
been conducted to elucidate the viral dynamics in pteropid bats in
order to better understand the timing and nature of spillover to
humans. Henipaviruses appear to have an acute shedding period
in bats. Experimental and natural infections in pteropid bats have
resulted in viral RNA detection in excreta up to 17 days post
infection and isolation within 3 weeks of apparent infection
respectively, making detection of infected individuals in the wild
challenging [2,13–15]. As a result, field studies have largely relied
on serological data to identify infection rates in free ranging bat
populations. Serological studies of Nipah and Hendra virus
antibodies in free-ranging pteropid bat colonies have found
seroprevalence to be as high as 59% [4,16–18]. However, viral
isolation and molecular studies suggest a very low (,1%) incidence
of infection [17,19].
Serum neutralization tests (SNTs) are considered the gold
standard for detecting specific antibodies to Hendra and Nipah
virus [20]. However, the use of SNTs have been limited,
particularly in countries where henipaviruses are enzootic, because
they are classified as select agents and require the highest level of
biocontainment (Biosafety level (BSL) 4) in order to work with the
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live viral cultures required to conduct neutralization assays. As
BSL 4 labs are not available in most countries where henipaviruses
occur, IgG Enzyme-linked immunosorbant assays (ELISAs) and
Luminex assays [21] have been used to test sera for anti-Nipah or
anti-Hendra antibodies because they can be performed under
standard biosafety conditions [4,22].
Using serological studies to understand the dynamics of
infectious agents in wildlife presents challenges. Few serological
assays have been validated for wildlife species. Further, antibodies
may cross react or cross-neutralize related viral antigens, which
can limit the specificity of assays. There is also very little
information available about maternal transfer of immunity in
pteropid bats, including how long specific antibodies remain in the
pup’s blood. This makes it difficult, in studies of wild bats, to
determine precisely when an animal was infected or whether a
subadult may still have residual maternal immunity.
Bats, in general, undergo hemochorial placentation; have a
similar repertoire of immunoglobulin subclasses (IgA, IgE, IgG
and IgM) to other placental mammals; and they likely transfer
maternal antibodies in utero like humans and non-human primates
[23–25]. In addition, bats have been found to have a higher
genetic diversity of variable heavy chain gene regions in their
antibody repertoire compared to other mammals [26,27].
Transmission of maternal immunity from mother to offspring
occurs either across the placenta or the mammary gland. Little is
known, in general, about Pteropus immunology. The structure of
gamma immunoglobulin (IgG) in pteropodid bats appears to be
consistent with other eutherian mammals [25]. The transfer of
maternal antibodies has been observed in captive pteropid bats
[15,17], though the primary mechanism has not been described.
In pteropid bat species that have been examined to date, the
placenta has a hemodichorial structure, similar to that of humans
and rabbits [28]. This type of placentation participates in the
active transfer of IgG in utero [29]. Detection of antibodies to
Menangle virus (MenV) in fetuses from Pteropus poliocephalus dams
seropositive to MenV supports the transplacental transfer of
maternal antibody in pteropid bats [30]. Pteropus alecto bats have a
high abundance of IgG in their milk, a feature generally associated
with species that transfer maternal immunity via colostrum to their
offspring [31,32]. Thus, it is possible that bats are capable of
transferring IgG both transplacentally and across the mammary
gland.
Differences in the kinetics of antibody responses have been
reported in some bats, compared to conventional laboratory
animals (reviewed in [33]). Antibodies appear to play a role in viral
immunity, as observed in bats vaccinated against rabies virus
compared to unvaccinated animals that succumb to disease [34].
The role of IgG antibodies in henipavirus infection in Pteropus spp.
is less certain, as infected bats may not have a measurable titer and
infected bats may shed virus despite having a measurable titer
[2,13]. Hendra virus antibodies have been found in Pteropus
conspicillatus pups two-six weeks old and born to seropositive dams,
and titers were proportionate to that of the dam [17]. Age-
stratified analyses of juvenile seroprevalence may help elucidate
viral incidence, provided the animal’s age can be accurately
assessed. A study of captive Pteropus vampyrus measured maternal
antibodies up to 14 months post-parturition [15]. An age-stratified
survey of Hendra virus in Little Red flying foxes (Pteropus scapulatus)
in Australia found that adult bats had an HeV seroprevalence of
approximately 20%, while pre-weaned individuals had a 56%
seroprevalence (n = 790) [35]. While juvenile seroprevalence could
indicate recent viral circulation within a bat colony, the presence
of maternal IgG may confound sero-epidemiological studies.
Interpreting serological data from juvenile bats is challenging
because the duration of maternal IgG in pups is unknown, and it is
difficult to accurately determine the age of a juvenile pteropid bat
that is independent from its dam but not yet sexually mature (,6–
24 months, depending on species)[36–38]. While the duration of
maternal antibodies has been described in humans and domestic
animals [39–44], there is little data available on the half-life or
duration of maternal antibodies in pteropid bats. A longitudinal
serological study of Hendra virus antibodies in P. scapulatus
measured a decrease of antibodies in wild caught juveniles after 6
months [35]. Due to the biosafety requirements for henipaviruses
and the associated costs of running experiments under BSL 4
conditions, few experimental infections have been conducted in
bats, and none have been conducted that have measured the
duration of maternal antibodies to henipaviruses in pups.
Here we describe two complementary studies designed to
determine the duration and half-life of maternal antibodies in key
bat reservoir species for henipaviruses: P. hypomelanus, a reservoir
for Nipah virus and P. alecto, a primary reservoir for Hendra virus
[3,5]. In the first experiment, we vaccinated members of a captive
breeding population of P. hypomelanus using a viral antigen closely
related to Nipah virus that would allow us to measure the duration
of maternal antibodies in their offspring under BSL 2 conditions.
In the second experiment, we measured the duration of maternal
antibodies to Hendra virus in pups born to naturally infected dams
in a captive colony of P. alecto.
Materials and Methods
Experiment 1: Duration of Maternal Antibodies Against
Canine Distemper Virus in Experimentally Vaccinated
Pteropus Hypomelanus
This work was conducted at the Lubee Bat Conservancy in
Gainesville Florida between 2007 and 2009 under IACUC CP07-
1 Epstein. Twenty adult female Pteropus hypomelanus were
introduced to two males under captive breeding conditions. After
a period of 2 weeks, the males were removed from the enclosure.
The females were checked for pregnancy every month using
ultrasound. None of the bats in this experiment had been
previously exposed to or vaccinated against canine distemper
virus. All bats had also tested negative for IgG antibodies against
Nipah virus at the Centers for Disease Control and Prevention
(unpublished data). Pregnant females were identified within 2
months of mating and separated into a cohort. Five pregnant bats
were vaccinated against canine distemper virus using a canarypox-
vectored canine distemper virus vaccine (Meriel, USA) according
to manufacturer’s instructions for dogs. We had previously
demonstrated that this dosing regimen elicits an immune response
in P. hypomelanus (unpublished data). Nine bats from the study
group (5 pregnant and 4 non-pregnant) and 5 control group bats
(non-mated) were given (1.0 ml) vaccine subcutaneously at days 0,
21, and 42 beginning at the third month of gestation. 1.0 ml of
blood was drawn from the bats prior to day 0 to establish a
negative titer, then blood was drawn on days 0, 3, 7, 28, 42 and 49
after initial dose and then every 30 days until the end of the study.
A blood sample (1.0 ml) was collected from either the radial
artery/vein or saphenous vein using a 25 or 27 g L’’ needle for
adults and a 1 ml tuberculin syringe for juveniles born to
vaccinated mothers every 30 days for 24 months or until negative
titers were obtained. Sampling began when the pups were a
minimum weight of 100 g, at approximately 4–6 weeks of age.
Sampling continued until we received titers at or below 16 at
which point we considered the titer to be ‘‘negative.’’ In dogs, a
protective titer is considered to be above 1:32 by the Cornell
Veterinary Diagnostic Lab [45], however, to date there have been
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no experimental challenges with CDV in bat species. The lab did
not heat-treat the plasma samples according to standard practice,
which allows active complement to non-specifically neutralize
virus at dilutions of 1:16 and below. Therefore, we considered a
titer of 16 to be the negative cutoff in this study.
Blood was placed in an EDTA tube (vaccutainer, BD USA) and
0.5 ml plasma was sent to the Animal Health Diagnostic Center at
Cornell University (Ithaca, NY) to measure the neutralizing
antibodies against CDV using a neutralization test. Briefly, 50 ml
of diluted plasma per well was added to 2 wells of a microtiter
plate containing an equal volume of test medium. Serial 2-fold
dilutions were done to the end of the plate. An equal volume of
CDV (Onderstepoort strain) containing 30–100 TCID50 of virus
was added to each well. Plates were incubated for at least 1 hr at
37uC. Then Vero cells were added in suspension to each well
(,20,000 cells per well). Plates were incubated for five days. Each
well was examined for presence of typical CDV cytopathology.
Wells were scored as positive or negative. Titer of plasma is the
reciprocal of the dilution calculated as a 50% end point.
Experiment 2: Duration of Maternal Antibodies Against
Hendra Virus in Offspring of Naturally Infected Pteropus
Alecto
This work was conducted at the CSIRO Australian Animal
Health Laboratory (AAHL) in Geelong, Victoria and all work was
approved by the AAHL animal ethics committee (protocols
AEC1474 and AEC1532). Pteropus alecto were captured in the
environs of Brisbane, Queensland using mist nets [17]. Bats were
Figure 1. Antibody response to inoculation with a canarypox vectored canine distemper virus vaccine in adult Pteropus
hypomelanus including those who were non-mated (control group); mated, non-pregnant; and mated, pregnant (colored lines).
Black triangles indicate the administration of the three doses of vaccine on days 0, 21, and 42. Named bats in the figure are the dam of the pups
described in figure 2.
doi:10.1371/journal.pone.0067584.g001
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caught and held under Queensland EPA Scientific permit
#WISP06386409 and Victorian Dept. of Primary Industries
(DPI)Scientific permit #13909659; bats were imported to Victoria
from Queensland under Victorian DPI Import permit
#13894504. Thirteen adult female bats that were determined to
be pregnant by abdominal palpation were brought into captivity at
AAHL in August 2011. All thirteen bats gave birth to a single pup
each between late October and early November 2011. Urine and
oropharyngeal swab specimens from all adult and neonatal bats
used in this experiment were screened and were negative for
Hendra virus RNA using RT PCR (data not shown).
Adult females were allowed to acclimatize for a period of one
week following transfer into captivity before samples were
obtained and pups were sampled from one month post-partum.
Blood was collected from adults and pups every 30 days until 12
months post-partum. Each adult animal was anaesthetized using
isoflurane, a gas anesthetic, and 2 ml of blood was obtained from
the cephalic vein using a 25 g needle. Pups were bled from the
Figure 2. Maternal antibody titers against canine distemper virus in five neonate Pteropus hypomelanus beginning at 1 month post-
parturition. The red dashed line indicates a negative titer cutoff of 16.
doi:10.1371/journal.pone.0067584.g002
Table 1. Initial and terminal half-lives (in days) for P.
hypomelanus.
Bat Pup Name Initial t1/2 (days) Terminal t1/2 (days)
America 35.33 91.00
Chibi 52.72 155.56
Vivi 25.44 62.50
Pups displayed bi-phasic rates of antibody decay. These calculations exclude
pups Cahya and Chesa because there were too few observations to calculate
the half-life.
doi:10.1371/journal.pone.0067584.t001
Duration of Maternal Antibodies in Fruit Bats
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e67584
cephalic vein using a 25 g needle attached to a Multivette tube
(Sarstedt) and 0.5–1 ml of blood was obtained monthly from one
month to 12 months post-partum. Blood was placed in serum
collection tubes (vaccutainer, BD USA). All sera were heat
inactivated at 56uC for 30 minutes prior to use. Sera were tested
for antibody binding to recombinant soluble Hendra virus G
glycoprotein (sGHEV) using a Luminex multiplexed binding assay
as described previously [21]. Briefly, sGHEV coupled microspheres
(Bio-Rad Laboratories, Inc) were incubated with sera (1:250),
followed by incubation with biotynylated Protein A/G (1:500)
(Pierce, Rockford, IL, USA), followed by streptavidin-phycoery-
thrin (1:1000) (Qiagen, Doncaster, Vic, Australia). Antibodies
bound to sGHEV coated beads were quantified by fluorescence and
read as the median fluorescence intensity (MFI) on a Bio-Plex
Protein Array System integrated with Bio-Plex Manager Software
(Bio-Rad Laboratories, Inc., CA, USA). MFI values ,200 were
considered negative [7].
In order to confirm Luminex results, serum neutralization tests
(SNTs) were performed on a subset of samples from pups 204 g
and 677 g and for selected time points for four adults as described
previously using a starting serum dilution of 1:20. Serum
neutralization was determined by the presence of cytopathic
effects (CPE) in the cellular monolayer and recorded as the serum
dilution where no CPE was evident [21]. All experiments utilizing
live virus were performed under BSL 4 conditions.
Half-life Calculation
Antibody decay rates were calculated using a two-compart-
mental model, based on [42]. The initial (distributive) phase
describes the equilibration of a biologic agent between the intra-
and extravascular spaces. The terminal phase or elimination
represents the actual use of the material [42,43]. Both phases can
be described by fitting independent linear models. This method
also allows the determination of confidence intervals and the
assessment of the model adequacy (e.g., if indeed there are two
phases). Where bi-phasic decay rates were detected, the terminal
half-life was used to represent the rate of antibody decay. Half-lives
were estimated fitting a non-parametric regression. These analyses
were performed using the statistical software R [44] and the
package PK [45]. Mean duration of immunity for each group was
compared using an unpaired student’s t-test [physics.csbsju.edu/
cgi-bin/stats/t-test]. Pups’ titers were compared using Welch’s t
test in the statistical software R.
Results
Experiment 1
All adult bats showed an immune response to the canine
distemper vaccine (Figure 1). Five P. hypomelanus pups were born
to vaccinated dams. The initial and terminal half-lives, which
represent the first and second phase of bi-exponential antibody
decay, were calculated for each pup and are presented in Table 1.
Two pups could not be used in the half-life calculation as they
dropped below the negative cutoff in fewer than four titer
measurements – the minimum required for the half-life calcula-
tion. These two pups, Cahya and Chesa, were twins belonging to
Charisma, and their starting titers (mean= 40, n= 2) were
significantly lower than the other three pups’ (mean=206.5,
Welch’s t = 6.94, df = 2.138, p = 0.017). The three remaining pups
showed bi-phasic CDV antibody half-lives. Titer curves for the
pups are presented in Figure 2. The geometric mean (GM) of the
initial half-life is 36.19 days (CI 95%: 14.6–89. 6); the GM of the
Terminal half-life is 96.0 days (CI 95%: 30.7–299.7). The mean
duration of immunity (titer above 16; n = 5) was 228.6 days (95%
CI: 185.4–271.8) ,7.6 months.
Experiment 2
Initial anti-Hendra virus antibody titers from the 13 adult P.
alecto and titers immediately preceding parturition are shown in
Figure 3. The serum antibody titer in samples collected close to
the birth of the pups displayed similar levels of HeVsG antibody to
those detected following capture. Twelve pups born to seropositive
dams had serum antibody to recombinant HeV sG and one pup
(pup 483) born to a seronegative dam was also seronegative (data
not shown). The titer curves of the pups from one to twelve
months post-partum are also presented in Figure 3. For
comparative purposes, SNTs were performed on pups pa204
and pa677 g demonstrating the presence of neutralizing antibody
to HeV (data not shown). The initial and terminal half-life for each
of the twelve seropositive pups and is shown in Table 2. Of the
twelve pups, only two appeared to have biphasic half-lives,
whereas 10 of 12 had initial half-lives equal to the terminal half-
lives, indicating a mono-phasic decay rate. The geometric mean
for the initial phase was 36.83 days (CI 95%: 29.82–45.48). The
geometric mean for the terminal phase was 52.24 days (CI 95%:
33.76–80.83). The mean duration of immunity (n = 8 bats) was
255.13 days (95% CI: 221.0–289.3) ,8.5 months. Four of the
12 pups in the study did not reach the negative cutoff within the
timeframe of the study, and were omitted from the calculation of
mean duration of immunity. There was no significant difference
between the mean duration of immunity for Experiment 1 and 2
(t =21.06; p = 0.3).
Discussion
Bats have become the subject of an increasing number of field-
based epidemiological studies due to their association with
zoonotic pathogens such as Ebola virus, Marburg virus, Nipah
virus, Hendra virus, SARS coronavirus, and most recently a novel
bat coronavirus in the Middle East– all of which cause mortality in
humans [46,47]. It has been suggested that outbreaks of viruses
within bat populations have been related to the waning of
Table 2. Initial and terminal half-lives (t K) for serum
antibody to sGHeV in P. alecto pups.
Pup ID Initial T K (days) Terminal T K (days)
pa677r 39.00 39.00
pa823 36.98 36.98
pa830 31.82 82.06
pa869 19.17 245.35*
pa923 39.19 39.19
pa677 g 63.17 63.17
pa387 39.92 39.92
pa253 37.12 37.12
pa204 43.99 43.99
pa133 37.87 37.87
pa62 34.24 34.24
pa43 38.98 38.98
Geometric mean 52.24 (+/228.59)
*Pup 869 (fWanda Markotterailed to thrive and was euthanized) and Pup 483
(seronegative) were removed from the table.
doi:10.1371/journal.pone.0067584.t002
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immunity in juvenile cohorts. Understanding the duration of
maternal antibodies in pteropid bats (and the age of the bat) will
help determine whether anti-henipavirus IgG in juveniles is
maternally-derived rather than the result of viral exposure. Each of
the two experiments presented here provide valuable data related
to bat immunology, however, there were limitations to interpreting
observed differences or similarities between the results from the
two experiments since they each involved different bat species and
different methodologies. Experiment 1 used a canarypox vectored
canine distemper virus vaccine as a proxy for Nipah virus
infection, which although it was the safest option, may not have
generated the same results had we been able to follow pups born to
P. hypomelanus dams naturally infected with NiV (as with HeV in
Experiment 2). Since the completion of Experiment 1, a
canarypox vectored Hendra virus vaccine has been developed,
and this may serve as a better surrogate for future studies requiring
lower biosafety conditions [48]. We expect that the results from
Experiment 2, which was based on a natural infection of a
pteropid bat with Hendra virus, are more likely to be comparable
to immune dynamics in closely related species infected with Nipah
virus compared to those from Experiment 1, though both studies
provided a controlled opportunity to measure immune system
dynamics in key Henipavirus reservoir species.
Previous age-stratified serological studies of henipaviruses in
pteropid bats have found that the sero-status of neonates matches
their dam [15,17,35,49]. Plowright et al., [50] described the
annual occurrence of HeV spillover events in Australia as
coinciding with the presence of a susceptible juvenile population
of bats and estimated that maternal antibody had waned by
approximately 6 months post-partum, coinciding with annual
HeV spillover events. Similarly, distinct pulses of Marburg virus
transmission in juvenile Rousettus aegyptiacus fruit bats at approxi-
mately 6 months post-partum have been reported [51]. A wave of
virus infection has also been detected in Myotis myotis bats
approximately one month after parturition which the authors
speculated may be associated with waning maternal antibody [52].
Figure 3. Anti-HeV titers in thirteen juvenile P. alecto from one month to 12 months post-partum. The anti-HeV titers of the dams are
shown as triangle with corresponding colors from the measurement immediately preceding birth. Initial juvenile titers were commensurate with that
of their dam. Titers are shown as median fluorescence intensities (MFI).
doi:10.1371/journal.pone.0067584.g003
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A study of Nipah virus in captive P. vampyrus found maternal IgG
to last approximately 14 months; however the exact age of the
pups in that study was uncertain, and two of the four died before
titers became negative [15]. We found that the calculated half-life
values of maternally derived antibody did not differ significantly
between pups from vaccinated bats (Experiment 1) and naturally
infected bats (Experiment 2). In experiment 2, four pups whose
titers did not fall below the negative threshold during the period of
measurement were omitted from calculation. However, if they had
an endpoint and were included, the mean duration of immunity
would have been lengthened, although it cannot be determined if
this would have created a statistically significant difference from
Experiment 1.
Bats in both experiments showed a similar duration of maternal
antibodies between 7.5 and 8.5 months in Experiments 1 and 2
respectively. Duration of maternal immunity is influenced by
multiple factors including the magnitude of the mother’s titer
during gestation (which can be affected by vaccination vs. natural
infection), the age of the neonate at parturition (premature
offspring tend to receive fewer antibodies) as well as antibody
decay rate in neonates. The duration of maternal antibodies to
measles virus in human infants has been shown to be longer in
those born to naturally infected mothers versus mothers who were
vaccinated [42]. The timeframes we observed are longer than the
suggested six months estimated at the population level for Hendra
virus in P. scapulatus [35]. However, our data from Experiment
2 do show a significant decrease in titer by six months, which
represents approximately 3.5 terminal half-life periods for Hendra
virus antibodies, or a decay to less than 1/8 of the starting titer,
which may result in sufficiently decreased herd immunity at the
population level to allow for viral circulation among the juvenile
cohort.
A direct correlation was observed between the seropositivity of
dams and their pups, with antibodies against CDV being detected
in all five pups born to vaccinated dams, and anti-HeV antibodies
detected in the 12 pups born to 12 seropositive dams and no HeV
antibodies in the one pup born to a seronegative dam. This result
is consistent with an earlier Hendra virus study demonstrating a
strong association between dam and pup serostatus [17]. It
appears from the data that the pups’ titers correlate with their
dam’s. Interestingly, we found that Charisma, who had the lowest
titer of the dams, produced twins (Chesa and Cayha) that had
significantly lower titers than their peers. We hypothesize that
there was correlation between the titers of dams and their pups,
however, in this case we did not have enough data to test this
statistically as the titers of Chesa and Cahya were not independent
of each other and would likely skew the correlation coefficient
towards significance.
We did not measure the decay rates of antibodies in adult bats,
however, we would expect them to be slower than that observed in
pups. Faster decay of maternally derived antibodies has been
reported in human infants born to vaccinated mothers compared
with naturally immune mothers [43,53].
Henipaviruses are an important group of zoonotic viruses
carried by Pteropus species, and understanding pteropid immunol-
ogy is important for modeling the dynamics of viral infections
within flying fox populations. Waning immunity to henipaviruses
in juvenile cohorts may be critical to the timing of outbreaks within
colonies, and therefore related to risk of spillover to humans and
other animals. Further study of bat immunology will be helpful
both for ecological studies of viral pathogens and also for
understanding how bats respond to viral infections.
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